| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3231375 | F | Antitumor activity against mouse Gardner lymphosarcoma allografted in C3H mouse assessed as tumor growth inhibition at 0.05 mg/kg, ip administered daily for 8 to 10 days | Mus musculus | 12 | organism-based format | Scientific Literature | ||
| 2. | ALA3231376 | F | Antitumor activity against mouse Gardner lymphosarcoma allografted in C3H mouse assessed as tumor growth inhibition at 0.10 mg/kg, ip administered daily for 8 to 10 days | Mus musculus | 28 | organism-based format | Scientific Literature | ||
| 3. | ALA3231377 | F | Antitumor activity against mouse Gardner lymphosarcoma allografted in C3H mouse assessed as tumor growth inhibition at 0.20 mg/kg, ip administered daily for 8 to 10 days | Mus musculus | 35 | organism-based format | Scientific Literature | ||
| 4. | ALA3231378 | F | Antitumor activity against mouse Gardner lymphosarcoma allografted in C3H mouse assessed as tumor growth inhibition at 0.30 mg/kg, ip administered daily for 8 to 10 days | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 5. | ALA3231379 | F | Antitumor activity against mouse Gardner lymphosarcoma allografted in C3H mouse assessed as tumor growth inhibition at 0.40 mg/kg, ip administered daily for 8 to 10 days | Mus musculus | 22 | organism-based format | Scientific Literature | ||
| 6. | ALA3231468 | F | Antitumor activity against mouse B16 cells allografted in C57BL/6 mouse assessed as prolongation of host survival at 0.60 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 11 | organism-based format | Scientific Literature | ||
| 7. | ALA3231469 | F | Antitumor activity against mouse B16 cells allografted in C57BL/6 mouse assessed as prolongation of host survival at 0.90 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 11 | organism-based format | Scientific Literature | ||
| 8. | ALA3231470 | F | Antitumor activity against mouse B16 cells allografted in C57BL/6 mouse assessed as prolongation of host survival at 1.20 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 8 | organism-based format | Scientific Literature | ||
| 9. | ALA3231479 | F | Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 1.6 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA3231480 | F | Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 1.2 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA3231481 | F | Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.9 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA3231482 | F | Antitumor activity against mouse P1534 cells allografted in DBA2 mouse assessed as tumor growth inhibition at 0.6 mg/kg, ip administered on days 1,5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA3231575 | T | Toxicity in iv dosed mouse assessed as lethality | Mus musculus | 5 | organism-based format | Scientific Literature | ||
| 14. | ALA3231576 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.08 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 15. | ALA3231577 | F | Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.80 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 16. | ALA3231901 | F | Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.08 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 17. | ALA3231902 | F | Antitumor activity against mouse P388/S cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.648 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 18. | ALA3231907 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 1.80 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 19. | ALA3231908 | F | Antitumor activity against mouse P388/VCR cells allografted in CD2F1 mouse assessed as increase in host lifespan at 0.648 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 20. | ALA3231912 | F | Antitumor activity against mouse P388/VCR cells allografted in B6D2F1 mouse assessed as increase in host lifespan at 1.20 mg/kg, ip administered on days 1, 5 and 9 | Mus musculus | 5 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!